Novavax COVID-19-vaksine (Norwegian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Novavax COVID-19-vaksine" in Norwegian language version.

refsWebsite

Global rank Norwegian rank

5doi.org

2^nd place

9^th place

4web.archive.org

1^st place

4nih.gov

4^th place

23^rd place

3reuters.com

49^th place

132^nd place

2bizjournals.com

407^th place

4,353^rd place

2cnbc.com

220^th place

689^th place

1livemint.com

390^th place

8,952^nd place

1bbc.com

20^th place

44^th place

1harvard.edu

18^th place

86^th place

1sciencemag.org

857^th place

279^th place

1fancycomma.com

low place

1novavax.com

low place

1docs.google.com

1,047^th place

870^th place

1washingtonpost.com

34^th place

136^th place

1theguardian.com

12^th place

35^th place

1gazettelive.co.uk

5,758^th place

low place

1thisistherealspain.com

low place

1bloomberg.com

99^th place

311^th place

1fiercepharma.com

low place

1statnews.com

8,771^st place

low place

1timesnownews.com

725^th place

low place

bbc.com

«New Covid vaccine shows 89% efficacy in UK trials». BBC News. 28. januar 2021.

bizjournals.com

«Novavax is working to advance a potential coronavirus vaccine. So are competitors.». Washington Business Journal. 26. februar 2020.
«Novavax's coronavirus vaccine program is getting some help from Emergent BioSolutions». Washington Business Journal. 10. mars 2020.

bloomberg.com

«Novavax Deal With Mabion Boosts Poland’s Nascent Biotech Scene». Bloomberg. 25. mars 2021.

cnbc.com

«Novavax starts clinical trial of its coronavirus vaccine candidate». CNBC. 25. mai 2020. Arkivert fra originalen 26. mai 2020. Besøkt 26. mai 2020.
«Novavax says Covid vaccine is more than 89% effective». CNBC. 28. januar 2020.

docs.google.com

«COVID-19 vaccine tracker (click on 'Vaccines' tab)». Milken Institute. 11. mai 2020. Arkivert fra originalen 6. juni 2020. Besøkt 12. mai 2020.

doi.org

«Novavax vaccine delivers 89% efficacy against COVID-19 in UK—but is less potent in South Africa». Science. 28. januar 2021. doi:10.1126/science.abg8101.
«The long shot». Science. 370 (6517): 649–653. November 2020. Bibcode:2020Sci...370..649W. PMID 33154120. doi:10.1126/science.370.6517.649.
«Novavax launches pivotal U.S. trial of dark horse COVID-19 vaccine after manufacturing delays». Science. 28. desember 2020. doi:10.1126/science.abg3441.
«COVID-19 Vaccine Frontrunners and Their Nanotechnology Design». ACS Nano. 14 (10): 12522–12537. Oktober 2020. PMC 7553041 . PMID 33034449. doi:10.1021/acsnano.0c07197.
«Nanoparticle-Based Strategies to Combat COVID-19». ACS Applied Nano Materials. 3 (9): 8557–8580. 25. september 2020. PMC 7482545 . doi:10.1021/acsanm.0c01978.

fancycomma.com

«Novavax: A SARS-CoV-2 Protein Factory to Beat COVID-19.». 24. juli 2020.

fiercepharma.com

«Novavax scores $384M deal, CEPI's largest ever, to fund coronavirus vaccine work». FiercePharma. 11. mai 2020.

gazettelive.co.uk

«60m doses of new covid-19 vaccine could be made in Billingham – and be ready for mid-2021». Reach. 14. august 2020.

harvard.edu

adsabs.harvard.edu

«The long shot». Science. 370 (6517): 649–653. November 2020. Bibcode:2020Sci...370..649W. PMID 33154120. doi:10.1126/science.370.6517.649.

livemint.com

«Hope to launch Covovax by September, says Serum Institute CEO». mint. 27. mars 2021.

nih.gov

ncbi.nlm.nih.gov

«The long shot». Science. 370 (6517): 649–653. November 2020. Bibcode:2020Sci...370..649W. PMID 33154120. doi:10.1126/science.370.6517.649.
«COVID-19 Vaccine Frontrunners and Their Nanotechnology Design». ACS Nano. 14 (10): 12522–12537. Oktober 2020. PMC 7553041 . PMID 33034449. doi:10.1021/acsnano.0c07197.
«Nanoparticle-Based Strategies to Combat COVID-19». ACS Applied Nano Materials. 3 (9): 8557–8580. 25. september 2020. PMC 7482545 . doi:10.1021/acsanm.0c01978.

nih.gov

«Phase 3 trial of Novavax investigational COVID-19 vaccine opens». National Institutes of Health (NIH). 28. desember 2020. Besøkt 28. desember 2020.

novavax.com

«Urgent global health needs addressed by Novavax». Novavax. Besøkt 30. januar 2021.

reuters.com

«Novavax signs COVID-19 vaccine supply deal with India's Serum Institute». Reuters. 5. august 2020.
«U.S. government awards Novavax $1.6 billion for coronavirus vaccine». Reuters. 7. juli 2020.
O’Donnell, Carl; Nadeem, Dania (11. mars 2021). «Novavax vaccine 96% effective against original coronavirus, 86% vs British variant in UK trial». Reuters.

sciencemag.org

«Novavax launches pivotal U.S. trial of dark horse COVID-19 vaccine after manufacturing delays». Science. 28. desember 2020. doi:10.1126/science.abg3441.

statnews.com

«Novavax says its Covid-19 vaccine is 90% effective in late-stage trial». Stat. 28. januar 2021. Besøkt 29. januar 2021.

theguardian.com

«Novavax Covid vaccine shown to be nearly 90% effective in UK trial». The Guardian. 28. januar 2021.

thisistherealspain.com

«Spain, again chosen to produce the vaccine to combat COVID-19». This is the Real Spain. 18. september 2020. Arkivert fra originalen 19. mars 2021. Besøkt 1. april 2021.

timesnownews.com

"Novavax Covid-19 vaccine gets EUA in Indonesia; Serum Institute to sell it under 'Covovax' brand name", Times Now, 1. november 2021

washingtonpost.com

«Maryland plays an outsized role in worldwide hunt for a coronavirus vaccine». Washington Post. Arkivert fra originalen 7. mai 2020. Besøkt 8. mai 2020.

web.archive.org

«COVID-19 vaccine tracker (click on 'Vaccines' tab)». Milken Institute. 11. mai 2020. Arkivert fra originalen 6. juni 2020. Besøkt 12. mai 2020.
«Maryland plays an outsized role in worldwide hunt for a coronavirus vaccine». Washington Post. Arkivert fra originalen 7. mai 2020. Besøkt 8. mai 2020.
«Spain, again chosen to produce the vaccine to combat COVID-19». This is the Real Spain. 18. september 2020. Arkivert fra originalen 19. mars 2021. Besøkt 1. april 2021.
«Novavax starts clinical trial of its coronavirus vaccine candidate». CNBC. 25. mai 2020. Arkivert fra originalen 26. mai 2020. Besøkt 26. mai 2020.